Physician profile
John Moon
NPI 1558456319
$2,167.75
in general payments reported to CMS, 2019-2025
9 companies · $50.00 in 2025
The $50.00 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,266 · 2021: $257 · 2022: $448 · 2023: $66.29 · 2024: $81.30 · 2025: $50.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $198.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $197.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,809.52 | 2019-2024 | |
| Davol INC. | $128.48 | 2021-2025 | Phasix Mesh |
| Tela Bio, INC. | $83.56 | 2022 | |
| W. L. Gore & Associates, INC. | $39.71 | 2022-2024 | Gore Enform Preperitoneal Biomaterial |
| Organogenesis INC. | $25.26 | 2023 | Puraply |
| Smith+Nephew, INC. | $24.06 | 2024 | Collagenase Santyl |
| Integra Lifesciences Corporation | $23.17 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Hartmann USA, INC. | $17.86 | 2023 | Zetuvit Plus |
| Sumitomo Pharma America, INC. | $16.13 | 2024 | Gemtesa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Moon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.